Aveanna Healthcare (AVAH) 2026 Jefferies Healthcare Services and Technology Conference summary
Event summary combining transcript, slides, and related documents.
2026 Jefferies Healthcare Services and Technology Conference summary
15 Sep, 2026Business performance and growth outlook
Achieved strong Q2 results and updated long-term growth algorithm based on positive OBBA impact and state budget clarity.
California Medicaid rate increase effective 1/1/2027 marks the 32nd state rate win, supporting updated guidance and long-term planning.
Continued execution on preferred payer and state government affairs strategies, focusing on efficiency, free cash flow, and deleveraging.
Home health and hospice segment, about 12% of revenue, is growing organically at 15%-16%, outpacing the market.
Updated PDS segment growth from 3%-5% to 5%-6%, with future growth driven mainly by volume and COLA-type rate adjustments.
State rate increases and payer strategy
Seven state rate wins in H1, with more expected in H2; 32 Medicaid states now covered, aiming for 40 in coming years.
Rate increases now expected every few years, with COLA-type adjustments and occasional large outliers like Wisconsin's 38% increase.
Preferred payer agreements now cover 65% of PDS volume, with runway to reach 70%-80% and expansion into new states.
Value-based care agreements remain a small but growing part of reimbursement, focused on shared savings and improved outcomes.
Operational efficiency and financial discipline
Free cash flow generation reached $75 million in H1, with similar expectations for H2 and a full-year target of $150 million.
Deleveraging remains a priority, targeting sub-3x leverage in the near term.
Automation in revenue cycle management has reduced DSO and reserve rates to historic lows across all divisions.
Integration of recent acquisitions, such as Family First, is on track to be completed by year-end.
Latest events from Aveanna Healthcare
- Preferred payer strategy and operational gains drive robust growth and margin expansion.AVAH
Deutsche Bank 2026 Healthcare Summit - Q2 2026 revenue up 13.7%, net income up 49.1%, and full-year guidance raised.AVAH
Q2 2026 - 2026 revenue surpassed $2.68 billion, driven by organic growth, M&A, and value-based care initiatives.AVAH
Investor presentation - Double-digit growth sustained by payer partnerships, acquisitions, and disciplined cost management.AVAH
Bank of America Home Care Conference - Accelerated growth and margin expansion driven by acquisitions, payer strategy, and financial discipline.AVAH
46th Annual William Blair Growth Stock Conference - Double-digit revenue and profit growth in 2025, robust 2026 outlook, and major acquisition announced.AVAH
Q4 2025 - Raised 2025 guidance and strong Q3 results highlight scalable, value-based growth and margin stability.AVAH
44th Annual J.P. Morgan Healthcare Conference - Q2 revenue rose 7% to $505M, adjusted EBITDA up 27.3%, guidance raised for 2024.AVAH
Q2 2024 - Q1 2025 saw 14% revenue growth, 93% EBITDA rise, and raised full-year guidance.AVAH
Q1 2025